Protease inhibitors
CA 2332492 A1 · Owner: Thompson, Scott Kevin · Inventors: Halbert, Stacie Marie; Thompson, Scott Kevin; Veber, Daniel Frank
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides diacyl carbohydrazide compounds and , pharmaceutically acceptable salts hydrates and solvates thereof, which , inhibit proteases including cathepsin K, pharmaceutical compositions of such compounds, novel intermediates of such compounds and methods for treating , diseases of excessive bone loss or cartilage or matrix degradation including , osteoporosis; gingival disease including gingivitis and periodontitis; arthritis, more specifically, osteoarthritis and rheumatoid arthritis; Paget's disease; hypercalcemia of malignancy; and metabolic bone disease comprising , inhibiting said bone loss or excessive cartilage or matrix degradation by administering to a …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 20, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 20, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 20, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.